Neva DiBlasi's Colleagues at TCR2 Therapeutics
Neva DiBlasi's Contact Details
HQ
617-949-5200
617-949-5200
Location
Greater Boston
Greater Boston
Company
TCR2 Therapeutics
TCR2 Therapeutics
Neva DiBlasi's Company Details
TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.
Frequently Asked Questions about Neva DiBlasi
Neva DiBlasi currently works for TCR2 Therapeutics.
Neva DiBlasi's role at TCR2 Therapeutics is Research And Development Co-Op.
Neva DiBlasi's email address is ***@tcr2.com. To view Neva DiBlasi's full email address, please signup to ConnectPlex.
Neva DiBlasi works in the BioTech/Drugs industry.
Neva DiBlasi's colleagues at TCR2 Therapeutics are Ruifang Wang, Timothy Hayden, Alana Hamilton, Gregg W., Michael Ph.D., Robert Hofmeister, Peter Olagunju and others.
Neva DiBlasi's phone number is 617-949-5200